INTRODUCTION
and fifth week of radiation (n = 160). About 6 weeks after completion of the neoadjuvant CRT all patients underwent TME, including low anterior resection (n = 54) and abdominoperineal resection (n = 3).
Imaging Schedule
Both, the contrast-enhanced CT and the MRI were performed after the neoadjuvant CRT. The imaging studies were generally scheduled four weeks after the completion of the neoadjuvant CRT to evaluate tumor response and treatment related complications. The surgery was performed two weeks after the imaging studies.
Imaging Technique
All contrast-enhanced abdominopelvic CT examinations were performed using 16-detector-row CT scanners (Brilliance; Phillocal recurrence, the total mesorectal excision (TME) has been recommended as the standard surgical practice for rectal cancer. It indicates the resection of the tumor-bearing rectum as well as the resection of the surrounding mesorectum by dissection along the investing mesorectal fascia (1, 2). Because the tumor involvement of the circumferential resection margin (CRM) is known to be strongly associated with the high local recurrence rate (1), the preoperative prediction of CRM involvement is important not only to decide the treatment strategy but also to predict the prognosis. With the evidence of severe randomized controlled trials (3, 4), the neoadjuvant chemoradiotherapy (CRT) has been accepted also as standard treatment in cases of locally advanced rectal cancer to ensure the eradication of extramural infiltrating tumors and a clear CRM.
Magnetic resonance imaging (MRI) has been accepted as a key imaging modality for the initial evaluation of rectal cancer before neoadjuvant CRT. Several studies have been published to assess a diagnostic performance of MRI in patients who underwent neoadjuvant CRT (5-10). Although MRI has the superiority regarding the tissue contrast, CT has several advantages over MRI in terms of quick whole-body reviews for the distant metastasis as well as a lower cost factor and a wider accessibility. However, there is still a dearth of knowledge about the CT in terms of local tumor evaluation especially on the CRM.
In this study, we aimed to measure the diagnostic accuracy of CT and MRI which were obtained after neoadjuvant CRT in the prediction of the local tumor stage and the CRM status of rectal cancer by using histopathology as the standard reference.
MATERIALS AND METHODS

Study Design and Setting
This retrospective study was carried out for patients who initially had a tumor stage T3 or greater or N positive rectal cancer and underwent a neoadjuvant CRT with subsequent TME. The study subjects were recruited from a 900-bed tertiary hospital Two reading sessions for CT and MRI were held with an interval of four weeks. During the interpretation, CT and MRI obtained before neoadjuvant CRT were also reviewed to refer the initial tumor extent, respectively. They were requested to record T and N stages using the TNM system (12) . Because the differentiation between T1 and T2 tumors is known to be virtually impossible on both CT and MRI (13), they were classified into T1/T2 group. A regional node was considered positive if the maximum short axis length was more than 5 mm (14) . The distance between the tumor and the potential CRM was measured as the shortest distance (in millimeters) from the outermost part of the tumor to the adjacent mesorectal fascia at the level of the maximum depth of penetration through the rectal wall on transverse images (Fig. 1) . The mesorectal fasicia was defined as a linear structure surrounding the mesorectum that shows soft tissue-density on CT and hypo-intensity on T2-weighted MRI. In cases of low rectal cancer where the mesorectal fascia didn't extend, the distance was measured from the tumor to the leavator ani muscle. For MRI, the measurement was conducted on T2-weighted images (Fig. 2) . Only the solid portion of the tumor was considered to be a tumor margin, but the fine spiculate border was not applied in the measurement. When a local tumor stage was considered to be T1/T2, the shortest distance to the potential CRM was measured from the bowel wall at the level ips Medical Systems, Cleveland, OH, USA). Intravenous nonionic contrast material (2 mL/kg; iopromide, Ultravist 370; Schering, Berlin, Germany) was administered at a rate of 3 mL/s. Bolus MRI was performed with a 1.5-T system (GyroscanIntera; Philips Medical Systems, Amsterdam, the Netherlands) by using a pelvic phased-array coil. Two-dimensional T1-weighted and T2-weighted fast spin-echo sequences were performed. All sequences were performed in the transverse, coronal and sagittal planes. The transverse planes were angled perpendicular to the long axis of the tumor by using the sagittal plane (11) . The imaging parameters for the T1-weighted sequences were a 15 cm field of view, a 4 mm section thickness, a 1 mm intersection gap, 500-582/9.5-13 (19) . p values less than 0.05 were considered statistically significant. All statistical analyses were performed using MedCalc, version 11.6.1 (MedCalc Software, Mariakerke, Belgium).
RESULTS
The study included 57 patients (mean age, 59.2 years; age range, 35-82 years). There were 33 male (mean age, 59.6 years; age range 41-82 years) and 24 female patients (mean age, 58.7 years; age range, 35-78 years). All patients underwent 5-fluorouracil based chemotherapy (either oral or intravenous) and 54 patients underwent low anterior resections. 52 patients had cT3 cancers, and 35 patients had malignant lymph nodes. Twenty patients had an involved CRM on the MRI which was obtained before the neoadjuvant CRT. Post-CRT pathologic staging and CRM status are summarized in Table 1 
Local Tumor Stage
Accuracies of T and N stages on CT and MRI after neoadjuvant CRT were shown on Table 2 . For T stage, the accuracy of MRI was significantly higher than that of CT in both observers (63.2% vs. 43.9%, p = 0.003, for Observer 1; 68.4% vs. 54.4%, p = and site of the tumor. In cases of the tumor invading the mesorectal fascia and leavator ani muscle or other adjacent organs, the distance was zero. When an enlarged lymph node or extramural tumor deposit was located closer to the potential CRM than to the primary tumor, this was used to measure the distance to the CRM (15, 16) .
Reference Standard
Histopathologic evaluation of the surgical specimen was performed by one gastrointestinal pathologist (H.S.L. with nine years of experience in gastrointestinal pathology) using the method of Quirke et al. (17) . After surgery, the specimens were inked to the circumferential resection plane and then fixed in formalin for 24 hours. During the histopathology examination, the local tumor stage was evaluated according to TNM system proposed by the American Joint Committee on Cancer Staging 6th edition (12) . The shortest distance between the outmost margin of the tumor and CRM was measured also (17) . The histopathology results for the local tumor stage and the distance to CRM served as the reference standard.
Statistical Analysis
The accuracy of T and N stage on CT and MRI were obtained and compared with each other using the McNemar's test. Cases of underestimation and overestimation were counted. The interobserver agreement for T and N stages was obtained on CT and Four of the 57 patients with complete tumor regression were Note.-*Determined on MRI obtained before neoadjuvant chemoradiotherapy by two radiologists in consensus. The cut-off distance for involved CRM was ≤ 2 mm. APR = abdominoperineal resection, CRM = circumferential resection margin, LAR = low anterior resection, LV = leucovorin, 5-FU = 5 fluorouracil 4). For Observer 1, the mean difference between the distances measured on MRI and histopathology was 1.2 mm (95% CI: 0.5 mm to 1.9 mm) and the limit of agreement was -3.8 mm (95% CI:
-5.0 mm to -2.6 mm) to 6.2 (95% CI: 5.0 mm to 7.4 mm) (Fig. 5 ).
For Observer 2, the mean difference between the distances measured on MRI and histopathology was 1.6 mm (95% CI: 0.8 mm to 2.4 mm) and the limit of agreement was -4.2 mm (95% CI:
-5.6 mm to -2.8 mm) to 7.3 (95% CI: 5.9 mm to 8.7 mm) ( excluded from the analysis for the distance to CRM because it was not measurable on histopathology. The Bland-Altman plots showed wide discrepancies between the measurements of the distance to CRM on each CT and MRI and those on histopathology. For Observer 1, the mean difference between the distances measured on CT and histopathology was 1.1 mm (95% CI: 0.2 mm to 2.1 mm) and the limit of agreement was -5.5 mm (95% CI:
-7.1 mm to -3.9 mm) to 7.7 (95% CI: 6.1 mm to 9.4 mm) (Fig. 3) .
For Observer 2, the mean difference between the distances measured on CT and histopathology was 2.2 mm (95% CI: 1.1 mm to 3.4 mm) and the limit of agreement was -6.1 mm (95% CI: weighted images were added to the evaluation. Nevertheless, a clear consensus has not been reached yet for the MRI interpretation criteria after neoadjuvant CRT (24) . Dimensional criterion of 5 mm cut-off were used in this study as they were conventionally used in our institution and thought to be more objective and simple. Considering that a local excision based on a false negative diagnosis might be more harmful to patients than TME based on a false positive diagnosis, the results may suggest the need for the additional imaging criteria to the dimensional criterion. while it turned out to be T3N0 on pathologic examination.
In N staging, both CT and MRI showed moderate accuracy with a tendency of underestimation. Several previous studies proposed diagnostic criteria according to the morphologic characteristics including border, texture and shape of lymph nodes (21, 22) .
Lambregts et al. (23) reported an increased diagnostic performance in the prediction of nodal involvement when diffusion- (26, 27) . So the discrepancies might be influenced due to this ongoing process of tumor regression. However, this influence seems not to be substantial based on the findings of Bland-Altman plots, which showed no strong tendency for an over-or underestimation.
The present study had limitations. First, the number of study participants was small. This limited the comparison of CT and MRI with an adequate statistical power. Second, the distance between the tumor and potential CRM was measured on transverse CT images and not on multi-planar reformation which would allow the image to be sectioned perpendicular to the tumor. The measurement of CRM on CT would be expected to be less accurate.
In conclusion, CT and MRI showed a limited performance in predicting the local tumor staging and CRM involvement in patients after neoadjuvant CRT although MRI tended to show a better performance than CT.
The study data can provide a guidance for the treatment planning for subjects with rectal cancer following neoadjuvant CRT. 
